{{Rsnum
|rsid=4808260
|Gene=ZNF626
|Chromosome=19
|position=20846271
|Orientation=plus
|GMAF=0.3168
|Gene_s=ZNF626
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 8.1 | 33.9 | 58.1
| HCB | 9.5 | 50.0 | 40.5
| JPT | 26.3 | 47.4 | 26.3
| YRI | 10.7 | 32.1 | 57.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 9.5 | 50.0 | 40.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=C
  |Pval=7E-6
  |OR=3.71
  |ORtxt=[2.08-5.34] mg/dL decrease
  |OA=1
}}